These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6631230)

  • 21. Different reactivities of high density lipoprotein2 subfractions with hepatic lipase.
    Mowri HO; Patsch W; Smith LC; Gotto AM; Patsch JR
    J Lipid Res; 1992 Sep; 33(9):1269-79. PubMed ID: 1402396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo metabolism of apolipoproteins A-I and E in patients with abetalipoproteinemia: implications for the roles of apolipoproteins B and E in HDL metabolism.
    Ikewaki K; Rader DJ; Zech LA; Brewer HB
    J Lipid Res; 1994 Oct; 35(10):1809-19. PubMed ID: 7852858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coupling of photoactivatable glycolipid probes to apolipoproteins A-I and A-II in human high density lipoproteins 2 and 3.
    Berkhout TA; Groot PH; van Belzen R; Wirtz KW
    J Lipid Res; 1985 Aug; 26(8):964-9. PubMed ID: 3930643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein A-I isoforms in human lymph: effect of fat absorption.
    Ghiselli G; Schaefer EJ; Light JA; Brewer HB
    J Lipid Res; 1983 Jun; 24(6):731-6. PubMed ID: 6411847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective proteolytic digestion as a method for the modification of human HDL3 structure.
    Swaney JB
    J Lipid Res; 1983 Mar; 24(3):245-52. PubMed ID: 6405003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracellular early and late modifications of human apolipoprotein A-II. Effect of glutamine- +1 to leucine substitution.
    Lopez J; Roghani A; Bertrand J; Zanni E; Kalopissis A; Zannis VI; Chambaz J
    Biochemistry; 1994 Apr; 33(13):4056-64. PubMed ID: 8142408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of lipoprotein species (LpA-I, LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men.
    Frey I; Kamps H; Baumstark MW; Berg A; Keul J
    Clin Chim Acta; 1992 Oct; 211(3):167-73. PubMed ID: 1458611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular biology of human apoA-I, apoA-II, apoC-II and apoB.
    Law SW; Lackner KJ; Fojo SS; Hospattankar A; Monge JC; Brewer HB
    Adv Exp Med Biol; 1986; 201():151-62. PubMed ID: 2432761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparative isotachophoresis of human plasma high density lipoproteins HDL2 and HDL3.
    Bittilo Bon G; Cazzolato G; Avogaro P
    J Lipid Res; 1981 Aug; 22(6):998-1002. PubMed ID: 7276757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial apolipoprotein A-I and C-III deficiency, variant II.
    Schaefer EJ; Ordovas JM; Law SW; Ghiselli G; Kashyap ML; Srivastava LS; Heaton WH; Albers JJ; Connor WE; Lindgren FT
    J Lipid Res; 1985 Sep; 26(9):1089-101. PubMed ID: 3934306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human plasma apolipoproteins A-IV-0 and A-IV-3. Molecular basis for two rare variants of apolipoprotein A-IV-1.
    Lohse P; Kindt MR; Rader DJ; Brewer HB
    J Biol Chem; 1990 Jul; 265(21):12734-9. PubMed ID: 1973689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein A-I metabolism in subjects with a PstI restriction fragment length polymorphism of the apoA-I gene and familial hypoalphalipoproteinemia.
    Roma P; Gregg RE; Bishop C; Ronan R; Zech LA; Meng MV; Glueck C; Vergani C; Giudici G; Brewer HB
    J Lipid Res; 1990 Oct; 31(10):1753-60. PubMed ID: 1981893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.
    Asztalos BF; Brousseau ME; McNamara JR; Horvath KV; Roheim PS; Schaefer EJ
    Atherosclerosis; 2001 May; 156(1):217-25. PubMed ID: 11369017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
    Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
    J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-II influences the substrate properties of human HDL2 and HDL3 for hepatic lipase.
    Mowri HO; Patsch JR; Gotto AM; Patsch W
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):755-62. PubMed ID: 8640403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, modification, and flotation properties of rat hepatocyte apolipoproteins.
    Hussain MM; Zanni EE; Kelly M; Zannis VI
    Biochim Biophys Acta; 1989 Jan; 1001(1):90-101. PubMed ID: 2912498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
    Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
    Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism.
    Walsh BW; Li H; Sacks FM
    J Lipid Res; 1994 Nov; 35(11):2083-93. PubMed ID: 7868986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.